» Articles » PMID: 30286808

The Therapeutic Potential of Bone Marrow Mesenchymal Stem Cells in Premature Ovarian Failure

Overview
Publisher Biomed Central
Date 2018 Oct 6
PMID 30286808
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

With the development of regenerative medicine, a variety of mesenchymal stem cells (MSCs) are increasingly considered for the treatment of premature ovarian failure (POF). Reportedly, bone marrow-derived MSCs (BMSCs) improve the ovarian reserve, which mainly depends on homing and paracrine activities. Furthermore, paracrine factors secreted by these stem cells play an important role in ovarian recovery. Relevant studies indicate that BMSC transplantation has some positive effects on the treatment of POF in animals, but BMSCs are not widely applied in clinical therapy. Clinical trials are ongoing despite the fact that several patients experiencing BMSC transplantation recover their normal menstrual cycles and even give birth to babies. In this review, we discuss the possible therapeutic mechanisms of BMSCs for POF, migration, antiapoptosis, antifibrosis, angiogenesis, anti-inflammation, immunoregulation, and oxidative stress, which provide the theoretical basis for further study and clinical therapy.

Citing Articles

Human urine stem cells protect against cyclophosphamide-induced premature ovarian failure by inhibiting SLC1A4-mediated outflux of intracellular serine in ovarian granulosa cells.

Gu H, Wang L, Zhang Y, Zhuo Y, Zhang Z, Wei X Cell Mol Biol Lett. 2025; 30(1):21.

PMID: 39972244 PMC: 11840982. DOI: 10.1186/s11658-025-00701-1.


Improvement of ovarian function in a premature ovarian failure mouse model using Vitex agnus-castus extract.

Soleimany Z, Siadat F, Farhadi M, Mirshaby Z, Sanadgol Z, Eyni H JBRA Assist Reprod. 2025; 29(1):117-126.

PMID: 39835794 PMC: 11867258. DOI: 10.5935/1518-0557.20240101.


Exosomes derived from hypoxic mesenchymal stem cells restore ovarian function by enhancing angiogenesis.

Qu Q, Liu L, Wang L, Cui Y, Liu C, Jing X Stem Cell Res Ther. 2024; 15(1):496.

PMID: 39709481 PMC: 11663355. DOI: 10.1186/s13287-024-04111-6.


A 0.2 T-0.4 T Static Magnetic Field Improves the Bone Quality of Mice Subjected to Hindlimb Unloading and Reloading Through the Dual Regulation of BMSCs via Iron Metabolism.

Wang J, Zhen C, Zhang G, Yang Z, Shang P Int J Mol Sci. 2024; 25(23).

PMID: 39684847 PMC: 11642155. DOI: 10.3390/ijms252313136.


Stem cell transplantation extends the reproductive life span of naturally aging cynomolgus monkeys.

Yan L, Tu W, Zhao X, Wan H, Wu J, Zhao Y Cell Discov. 2024; 10(1):111.

PMID: 39496598 PMC: 11535534. DOI: 10.1038/s41421-024-00726-4.


References
1.
Figueroa F, Carrion F, Villanueva S, Khoury M . Mesenchymal stem cell treatment for autoimmune diseases: a critical review. Biol Res. 2013; 45(3):269-77. DOI: 10.4067/S0716-97602012000300008. View

2.
Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, Patil S . Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol. 2002; 30(1):42-8. DOI: 10.1016/s0301-472x(01)00769-x. View

3.
Xia X, Yin T, Yan J, Yan L, Jin C, Lu C . Mesenchymal Stem Cells Enhance Angiogenesis and Follicle Survival in Human Cryopreserved Ovarian Cortex Transplantation. Cell Transplant. 2014; 24(10):1999-2010. DOI: 10.3727/096368914X685267. View

4.
Zhang Y, Xia X, Yan J, Yan L, Lu C, Zhu X . Mesenchymal stem cell-derived angiogenin promotes primodial follicle survival and angiogenesis in transplanted human ovarian tissue. Reprod Biol Endocrinol. 2017; 15(1):18. PMC: 5343383. DOI: 10.1186/s12958-017-0235-8. View

5.
Guo J, Gao X, Lin Z, Wu W, Huang L, Dong H . BMSCs reduce rat granulosa cell apoptosis induced by cisplatin and perimenopause. BMC Cell Biol. 2013; 14:18. PMC: 3640998. DOI: 10.1186/1471-2121-14-18. View